ycopene and wheat bran extract in melasma

Phase 2

• Conditions: Melasma.; Melasma; L00-L99

• Registration Number: IRCT20190930044932N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Melasma diagnosis for patient
Signed informed consent

Exclusion Criteria

Pregnant or lactating
Use of corticosteroids and anticonvulsants and contraceptives
History of allergy to wheat bran extract or lycopene
Taking topical medications in the past month on face

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Skin color change stain area. Timepoint: Every three weeks up to 4 months. Method of measurement: The melasma area and severity index.;Patient satisfaction. Timepoint: Every three weeks up to 4 months. Method of measurement: Descriptive in terms of patient good, moderate, poor.;Stain area. Timepoint: Every three weeks up to 4 months. Method of measurement: the melasma area and severity index.